GRM5 and stroke disorder: Here we show for the first time, and unequivocally, that treatment with mGluR5 NAMs starting 2–10 days after stroke, i.e. outside the neuroprotective therapeutic time window,67 enhances recovery of sensorimotor functions without affecting infarct size, implying that processes outside of the matured infarct facilitate recovery.